Sexual Transmission of HCV Among MSM

Daniel S. Fierer, MD
Professor of Medicine, Infectious Diseases
Icahn School of Medicine at Mount Sinai
New York, NY

CME VIDEOTop of page

How to Obtain CME Credit:Top of page

Click here to take the CME Evaluation and Post-Meeting Survey

About the Presenter:Top of page

Daniel S. Fierer, MD, is Professor of Medicine and Infectious Diseases at the Icahn School of Medicine at Mount Sinai. In 2006, his group at Mount Sinai recognized the apparent sexual acquisition of hepatitis C virus (HCV) in men who have sex with men (MSM). In response, he developed the first prospective cohort of early HCV infection in MSM in the US through collaboration with over 50 providers of primary care to people with HIV infection in New York City. Through this cohort, and in collaborations with investigators and public health authorities in the US, Europe, and Australia, he has worked to characterize this previously occult pandemic. He has led the field in defining the mechanisms of transmission, the epidemiology, and the pathogenesis of liver disease, as well as advancing the treatment of early infection and promoting early detection and universal treatment, ultimately to improve the lives of people who acquire HCV infection.

Learning Objectives: Top of page

At the completion of this educational activity learners will:
1. Discuss the epidemiology of sexually transmitted HCV among MSM.
2. Describe the main behavioral risk factors for sexual transmission of HCV.
3. Discuss the body fluids most likely to be involved in sexual transmission of HCV.
4. Identify the optimal test types and intervals to monitor for primary HCV and reinfection.

CME Information:Top of page

This CME activity has approved for AMA PRA Category 1 Credit™ for May 10th, 2023 as a live activity.  This activity will also be available as an enduring activity from May 17th, 2023, through May 9th, 2026.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:Top of page

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun (Course Director/Planner) has no relevant financial relationships to disclose.
- Dr. Brianna Norton (Moderator) has no relevant financial relationships to disclose.
- Dr. Daniel S. Fierer (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Research grants from Merck & Gilead paid directly to the Icahn School of Medicine at Mount Sinai. Dr. Fierer submitted his slides in advance for adequate peer review and supported his presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

You must be logged in to post a comment. Login | Register